About Us
Founded in 1944, the American Committee for the Weizmann Institute of Science develops philanthropic support for the Weizmann Institute in Israel, and advances its mission of science for the future of humanity.
Apr 14, 2023... REHOVOT, ISRAEL—April 13, 2023 — The journey to Jupiter has begun. The European Space Agency’s unmanned spacecraft JUICE (short for JUpiter ICy moons Explorer) is launching today from Europe’s Spaceport in French Guiana. JUICE’s voyage, the ESA’s most ambitious mission to date, will be particularly lengthy: Upon reaching Jupiter’s orbit by 2031, it will embark on a four-year mission to investigate three of Jupiter’s moons – Callisto, Europa and Ganymede – as well as the composition of Jupiter’s atmosphere
Apr 23, 2023... REHOVOT, ISRAEL—April 27, 2023—To get life-giving oxygen into every cell, the human body produces two to three million oxygen-carrying red blood cells, or erythrocytes, each second – about one-quarter of all the new cells that are produced in the body at any one time. This process is controlled by the hormone erythropoietin, commonly known as EPO, which works by binding to cells in the bone marrow that are poised to become erythrocytes, promoting their proliferation. Erythropoietin was discovered decades ago, but the identity of the cells that make this hormone remained unknown – until now.
May 04, 2023... What is the future of solar technology? Weizmann Institute researchers are designing intelligent materials to capture sunlight in new, sustainable and unlimited ways. At this critical point for planet Earth, the role of science and its ability to provide transformative scientific solutions to our planet’s most pressing crisis is pivotal. Weizmann Institute scientists are tackling core issues affecting climate change and are engaged in sustainability research that is driven by an unprecedented sense of urgency. For the future of humanity
May 18, 2023... Dr. Moran Shalev Benami discusses her research on the tiniest details of the human brain: proteins. Using cryo-electron microscope (cryoEM), she works to understand and identify the proteins’ function and how proteins work together.
May 24, 2023...
To get life-giving oxygen into every cell, the human body produces two to three million oxygen-carrying red blood cells each second, a process controlled by the hormone erythropoietin (EPO), which works by binding to cells in the bone marrow and promoting their proliferation. Discovered decades ago, the identity of the cells that make this hormone remained unknown – until now.
In a new paper, published in Nature Medicine, Weizmann scientists from Prof. Ido Amit’s lab and colleagues from Israel, Europe, and the United States have identified a rare subset of kidney cells that are the main producers of EPO in the human body, a discovery that has transformative potential for patients with anemia.
Sep 06, 2023... Scientists grow whole model of human embryo, without sperm or egg
Sep 07, 2023... Lab-grown human "embryo-like structures" bring hope for research into early-pregnancy complications
https://www.weizmann-usa.org/news-media/feature-stories/the-romance-of-math/
Nov 01, 2023...
Watch Orna and Shmuel Kliger return to the Weizmann Institute of Science and reflect on how special their time there was and the profound impact it’s had on their lives.
For Orna and Shmuel Kliger, a set of advanced degrees in computer science from Weizmann has added up to a whole greater than the sum of its parts: two degrees were the starting point of a marriage, four kids, and major career success in the high-tech industry.
Mar 26, 2024...
Jerusalem, March 26, 2024 – The Blavatnik Family Foundation, the Israel Academy of Sciences and Humanities and The New York Academy of Sciences announced today the Laureates of the 2024 Blavatnik Awards for Young Scientists in Israel. This year’s Laureates, who will each receive $100,000, are:
Schraga Schwartz, PhD (Life Sciences) – Weizmann Institute of Science – Recognized for developing groundbreaking analytical methods to locate and quantify chemical changes in RNA. Professor Schwartz’s breakthroughs in understanding RNA modifications hold promise for treating genetic diseases and expanding the role of RNA editing beyond vaccine development.